PHGE 8-K: Press Release Furnishes Q2 2025 Financial Results

Rhea-AI Filing Summary

BiomX Inc. furnished an 8-K reporting that it issued a press release announcing its financial results for the quarter ended June 30, 2025. The filing does not include the underlying financial statements or numeric results; instead, the press release itself is furnished as Exhibit 99.1 and an Inline XBRL cover page is included as Exhibit 104.

The submission is a disclosure furnishing rather than a full presentation of results within the 8-K text. The report is signed on behalf of the company by Chief Executive Officer Jonathan Solomon.

Insights

Financial Analyst

TL;DR: Routine furnishing of a press release with Q2 2025 results; filing contains no financial data to evaluate impact.

The 8-K notifies investors that the company has publicly released its second quarter results and has attached that press release as Exhibit 99.1. Because the filing text itself does not include revenue, profit, cash flow, or other metrics, there is insufficient information here to assess earnings performance, trends, or valuation impact. Investors must review the referenced press release and any filed financial statements for material details.

Corporate Governance Expert

TL;DR: Procedural disclosure shows governance compliance in furnishing required press release exhibits; no governance issues disclosed.

The report follows standard disclosure practice by furnishing the press release as an exhibit and embedding Inline XBRL cover data. The filing identifies the signing officer as CEO Jonathan Solomon. The document does not present any executive changes, board actions, or governance-related transactions, so there is no material governance information to evaluate within this filing.

false 0001739174 0001739174 2025-08-13 2025-08-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 13, 2025

BiomX Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware		001-38762		82-3364020
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

22 Einstein St., Floor 4 Ness Ziona, Israel		7414003
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: +972 723942377

n/a

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value		PHGE		NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

Item 2.02 Results of Operations and Financial Condition.

On August 13, 2025, BiomX Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2025. A copy of the press release issued in connection with the announcement is furnished pursuant to this Item 2.02 as Exhibit 99.1 hereto.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit		Description
99.1		Press Release dated August 13, 2025 (furnished herewith)
104		Cover Page Interactive Data File (embedded within the Inline XBRL documents)

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	BIOMX INC.
August 13, 2025	By:	/s/ Jonathan Solomon
		Name:	Jonathan Solomon
		Title:	Chief Executive Officer

2

FAQ

What did BiomX (PHGE) disclose in this 8-K?

The company disclosed that it issued a press release announcing its financial results for the quarter ended June 30, 2025, and furnished that press release as Exhibit 99.1.

Does the 8-K include financial statements or numeric results for Q2 2025?

No. The 8-K text does not include numeric financial results or financial statements; the press release itself is furnished as an exhibit.

Which exhibits are attached to the filing?

The filing lists Exhibit 99.1 (Press Release dated August 13, 2025) and Exhibit 104 (Cover Page Interactive Data File embedded in Inline XBRL).

Who signed the 8-K for BiomX?

The report is signed on behalf of BiomX by Jonathan Solomon, Chief Executive Officer.

What class of securities is listed for BiomX and where is it traded?

The filing shows Common Stock, $0.0001 par value trading under the symbol PHGE on the NYSE American exchange.